News from MarketWatch Top Stories

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Ceo Tariffs Cryptocurrency Crypto Assets Investors Stocks Ethereum Shares Stock Market Stock Markets Xrp Price Blockchain Sec Investment Eth Etf Stablecoin Trade Earnings Revenue Solana China Coinbase Bse Index Usd Token Nasdaq Wall Street Trade War Ipo Inflation Profit Economy Digital Assets Interest Rates Nvidia Gold Binance Sp 500 Sensex Federal Reserve Trade Deal Company Investor Capital Raise Jerome Powell Fed Decision Crypto Reserve Bill Epl Prepaid Cards State Regulator Growth Stocks Has Lewi Korsinsky

Filter by:

Copd × MarketWatch Top Stories ×

MarketWatch Top Stories • May 30, 2025

Regeneron dashes Wall Street’s hopes as COPD treatment trial suffers a failure

The unsuccessful outcome of Regeneron’s advanced COPD therapy study led to a significant decline in its stock value, marking the company’s largest drop in over a decade on financia...

Read Full Article →